News for 'Astra Zeneca'

New Covid variant: Scientists warn against more mutations

New Covid variant: Scientists warn against more mutations

Rediff.com22 Dec 2020

Over time, as more mutations occur, the vaccine may need to be altered.

Rediff said it first! UK PM Boris Johnson will be Republic Day chief guest

Rediff said it first! UK PM Boris Johnson will be Republic Day chief guest

Rediff.com15 Dec 2020

Johnson will be only the second British leader since Indian independence to attend the annual Republic Day parade in New Delhi as Guest of Honour, after former prime minister John Major in 1993.

Never spoke about vaccinating entire country: Govt

Never spoke about vaccinating entire country: Govt

Rediff.com2 Dec 2020

Indian Council of Medical Research Director General Balram Bhargava said the purpose of the COVID vaccine drive would be to break the chain of viral transmission.

'More efficient use of vaccines is need of the hour'

'More efficient use of vaccines is need of the hour'

Rediff.com12 Apr 2021

'When there is so much anxiety, the Government of India should assure people on the vaccine issue and help the states demanding more supply that they will be provided the required quantities.' 'Any Centre-state conflict at this point of time is counter-productive and enhances people's anxieties that should be avoided.'

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

2nd phase of vaccine to cover 60+, include private centres

2nd phase of vaccine to cover 60+, include private centres

Rediff.com25 Feb 2021

The second phase of Covid-19 vaccination in India will begin from March ,1 in which people above 60 years of age and those above 45 years of age with comorbidities will be vaccinated, Union Minister Prakash Javadekar said on Wednesday.

ASK AJIT: Will these shares make me rich?

ASK AJIT: Will these shares make me rich?

Rediff.com30 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

Markets likely to be volatile ahead of derivative expiry

Markets likely to be volatile ahead of derivative expiry

Rediff.com27 Mar 2016

Short-covering and the propping up of net asset values have potential to boost frontline as well as second-rung names next week

India's vaccine diplomacy with the Maldives

India's vaccine diplomacy with the Maldives

Rediff.com25 Feb 2021

COVID-19 has emerged as an important form of diplomatic currency around the world as nations try to showcase their soft power gains. In this race, India has an edge as India is already a pharmaceutical giant having produced some 60 per cent of global vaccines and now justly seeking to strengthen ties and expand its influence in its neighbourhood and beyond, observes Dr Rajaram Panda.

India's Quest For A Role In The Future Of Semiconductors

India's Quest For A Role In The Future Of Semiconductors

Rediff.com28 Dec 2021

'Whoever owns the best chip industry will be the Saudi Arabia of the era of data,' predicts Rajeev Srinivasan.

India rehearses for massive coronavirus vaccination drive

India rehearses for massive coronavirus vaccination drive

Rediff.com2 Jan 2021

The dry-run was being conducted in state capitals in at least three session sites. Some states also included districts that are situated in difficult terrain or have poor logistical support, according to officials.

'Economic recovery depends a lot on vaccination'

'Economic recovery depends a lot on vaccination'

Rediff.com1 Jul 2021

'Vaccination is very important for an economy to start functioning properly.'

5 Foreign Destinations That Don't Require RT-PCR

5 Foreign Destinations That Don't Require RT-PCR

Rediff.com17 Mar 2022

India is ready, after battling the pandemic for two years, to travel once again.

Pegasus Project: Why I am hesitant to defend the government but must

Pegasus Project: Why I am hesitant to defend the government but must

Rediff.com22 Jul 2021

Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.

Markets end at record highs; ITC, banks outperform

Markets end at record highs; ITC, banks outperform

Rediff.com27 Jan 2015

The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.

Centre to bear expenses for first round of vaccination: PM

Centre to bear expenses for first round of vaccination: PM

Rediff.com11 Jan 2021

Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month.

What's delaying India's STUDY ABROAD plans?

What's delaying India's STUDY ABROAD plans?

Rediff.com29 Jun 2021

Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.

How Serum and Bharat battled for COVID-19 vaccine

How Serum and Bharat battled for COVID-19 vaccine

Rediff.com23 Apr 2021

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

Sensex, Nifty fall drastically at close; banks, auto lose heavily

Sensex, Nifty fall drastically at close; banks, auto lose heavily

Rediff.com11 Jun 2015

Sensex, Nifty end the day in red on unfavourable cues from global markets.

Markets end lower on May F&O expiry; Sensex sheds 58 points

Markets end lower on May F&O expiry; Sensex sheds 58 points

Rediff.com28 May 2015

Sensex eneded lower on poor perfromance by financials and IT stocks.

Vaccination drive hailed as decisive moment in fight against COVID-19

Vaccination drive hailed as decisive moment in fight against COVID-19

Rediff.com17 Jan 2021

Loud applause and cheers rang out as the first jabs were administered to frontline workers at hospitals and healthcare centres across the country on Saturday at the start of the gargantuan COVID-19 vaccination exercise, hailed as a 'momentous' occasion in India's fight against the pandemic.

Vaccine drive set in motion, 13 cities get first consignment

Vaccine drive set in motion, 13 cities get first consignment

Rediff.com12 Jan 2021

A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.

'We haven't heard the last about Omicron'

'We haven't heard the last about Omicron'

Rediff.com31 Dec 2021

'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'

'White House has heard us'

'White House has heard us'

Rediff.com28 May 2021

'They are starting to move more quickly and we would just like to continue to see bold action being taken.'

'Omicron produces less severe illness'

'Omicron produces less severe illness'

Rediff.com9 Dec 2021

'What prevents infection are masks, physical distancing and good ventilation.'

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

India blundered along, exactly as every other country did

India blundered along, exactly as every other country did

Rediff.com23 Jun 2021

Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.

Should post vaccine reactions be better monitored?

Should post vaccine reactions be better monitored?

Rediff.com17 May 2021

'There is more likelihood of dying from lightning than from vaccine induced blood clots.'

India rolls out world's largest vaccination drive against COVID-19

India rolls out world's largest vaccination drive against COVID-19

Rediff.com17 Jan 2021

The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

Covid: What is Delta, Delta Plus & can vaccines fight it?

Covid: What is Delta, Delta Plus & can vaccines fight it?

Rediff.com24 Jun 2021

While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.

'Both vaccines will be similar in immunity'

'Both vaccines will be similar in immunity'

Rediff.com11 Jan 2021

'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'

'Why did the government delay the vaccine?'

'Why did the government delay the vaccine?'

Rediff.com14 Apr 2021

'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'

COVID-19: 'There will be some spikes'

COVID-19: 'There will be some spikes'

Rediff.com19 Feb 2021

'It is absolutely important for us to continue to message to people that they must wear masks, keep physical distancing, as much as is practically possible, at work or at home.'

Please note: Life after vaccine won't be normal

Please note: Life after vaccine won't be normal

Rediff.com20 Dec 2020

'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'

Do you own these stocks? EXIT them NOW

Do you own these stocks? EXIT them NOW

Rediff.com22 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.